-
ALSO READ
Dry run for Covid-19 vaccine administration to be conducted in Agra today
Coronavirus vaccine dry run scheduled at 8 centres in Delhi today
Coronavirus vaccination dry run to be held in UP's Varanasi today
Maharashtra: Covid vaccine dry run to be conducted tomorrow in 4 districts
Dry run for Covid-19 vaccine on Dec 28, 29 in two Punjab districts
-
A dry run to assess the readiness
for the COVID-19 vaccination drive will be held in 21 districts of Chhattisgarh over the next two days, a senior state health official said on Wednesday.
Last week, a similar mock drill was held in Chhattisgarh's capital Raipur and six other districts out of the total 28 districts in the state.
Now, it will be held in the remaining 21 districts for the assessment of preparation for the imminent coronavirus vaccination drive, mission director for National Health Mission in Chhattisgarh, Priyanka Shukla, told PTI.
The dry run will be conducted in Balrampur, Bijapur, Dantewada, Jashpur, Kanker, Kondagaon, Korea, Narayanpur, Sukma and Surajpur districts on Thursday, and in Balod, Raigarh, Balodabazar, Bemetara, Dhamtari, Gariaband, Janjgir- Champa, Kawardha, Korba, Mahasamund and Mungeli on Friday, the official said.
The chief medical and health officers (CMHOs) of these districts have been directed to make necessary arrangements for the drill that will be held in one urban and one rural centre of each district from 10 am to 2 pm, she said.
After 5 pm, the district task force concerned will review the entire process and submit its report by January 9, the official said.
All necessary preparations like the selection of place, sending and receiving of mock vaccines, preparation of session in the Co-WIN app, and appointment of invigilator at the centre will be completed before the drill, she added.
Prior to the dry run, a state-level monitoring team will inspect the vaccination centres, she added.
Chhattisgarh's COVID-19 caseload reached 2,84,536 on Tuesday. Of these, 2,71,988 people have so far recovered, while 3,437 patients have till now died due to the disease, as per official figures.
The Drugs Controller General of India on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU